Page last updated: 2024-11-02

pca 4248 and Innate Inflammatory Response

pca 4248 has been researched along with Innate Inflammatory Response in 3 studies

PCA 4248: structure given in first source; platelet activating factor antagonist

Research Excerpts

Excerpt	Relevance	Reference
"Zymosan-induced articular hyperalgesia, oedema and neutrophil migration were dose-dependently reduced following pretreatment with selective PAFR antagonists, UK74505 (5, 10 and 20 mg/kg) and PCA4248 (3, 10, 30 mg/kg)."	1.39	The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. ( Cunha, FQ; Cunha, TM; Ferreira, SH; Guerrero, AT; Pinto, LG; Verri, WA; Vieira, SM; Zaperlon, AC; Zarpelon, AC, 2013)

1 review available for pca 4248 and Innate Inflammatory Response

Article	Year
Inflammation and melanoma growth and metastasis: the role of platelet-activating factor (PAF) and its receptor. Cancer metastasis reviews, 2007, Volume: 26, Issue:3-4 Topics: Animals; Cyclic AMP Response Element-Binding Protein; Dihydropyridines; Humans; Inflammation; Lung N	2007

2 other studies available for pca 4248 and Innate Inflammatory Response

Article	Year
The role of PAF/PAFR signaling in zymosan-induced articular inflammatory hyperalgesia. Naunyn-Schmiedeberg's archives of pharmacology, 2013, Volume: 386, Issue:1 Topics: Animals; Dihydropyridines; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperalgesia; I	2013
A role for inflammatory mediators in the induction of immunoregulatory B cells. Journal of immunology (Baltimore, Md. : 1950), 2006, Oct-01, Volume: 177, Issue:7 Topics: Adoptive Transfer; Animals; Antigens, CD19; B-Lymphocytes; Dermatitis, Contact; Dihydropyridines; Fl	2006